(Z)-2-(2-methoxy-5-(3,4,5-trimethoxystyryl)phenoxy)ethyl-4-(4-(((diethoxyphosphoryl)(4-methoxyphenyl)methyl)amino)phenyl)butanoate

ID: ALA5268402

Chembl Id: CHEMBL5268402

Max Phase: Preclinical

Molecular Formula: C42H52NO11P

Molecular Weight: 777.85

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOP(=O)(OCC)C(Nc1ccc(CCCC(=O)OCCOc2cc(/C=C\c3cc(OC)c(OC)c(OC)c3)ccc2OC)cc1)c1ccc(OC)cc1

Standard InChI:  InChI=1S/C42H52NO11P/c1-8-53-55(45,54-9-2)42(33-18-22-35(46-3)23-19-33)43-34-20-15-30(16-21-34)11-10-12-40(44)52-26-25-51-37-27-31(17-24-36(37)47-4)13-14-32-28-38(48-5)41(50-7)39(29-32)49-6/h13-24,27-29,42-43H,8-12,25-26H2,1-7H3/b14-13-

Standard InChI Key:  NIYGCIKPYJZPQZ-YPKPFQOOSA-N

Alternative Forms

  1. Parent:

    ALA5268402

    ---

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MGC-803 (6426 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP2 Tchem Matrix metalloproteinase-2 (6627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP3 Tchem Matrix metalloproteinase 3 (3433 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP9 Tchem Matrix metalloproteinase 9 (6779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 777.85Molecular Weight (Monoisotopic): 777.3278AlogP: 9.22#Rotatable Bonds: 23
Polar Surface Area: 129.24Molecular Species: NEUTRALHBA: 12HBD: 1
#RO5 Violations: 3HBA (Lipinski): 12HBD (Lipinski): 1#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.65CX Basic pKa: 0.26CX LogP: 7.74CX LogD: 7.74
Aromatic Rings: 4Heavy Atoms: 55QED Weighted: 0.03Np Likeness Score: -0.24

References

1. Huang X, Chen Y, Zhong W, Liu Z, Zhang H, Zhang B, Wang H..  (2022)  Novel combretastatin A-4 derivative containing aminophosphonates as dual inhibitors of tubulin and matrix metalloproteinases for lung cancer treatment.,  244  [PMID:36252396] [10.1016/j.ejmech.2022.114817]

Source